Exacerbations (OCS) · people with asthma
Adherence education showed no clear difference in exacerbations requiring OCS (people with 1 or more) WMD of compared with controls (low certainty).
1 finding from 1 review
Change in quality of life (ITG‐ASF) · people with asthma
1 finding from 1 review
All adverse events · people with asthma
Simplified showed no clear difference in all adverse events compared with usual regimens (low certainty).
1 finding from 1 review
Unscheduled visits 1 or more hospitalisations for any cause WMD of · children with asthma
School‐based ICS therapy showed no clear difference in unscheduled visits 1 or more hospitalisations for any cause WMD of compared with home therapy (low certainty).
1 finding from 1 review
Quality of life (PACQLQ) · children with asthma
1 finding from 1 review
Adverse events · children with asthma
1 finding from 1 review
Asthma control · people with asthma
2 findings from 1 review
Unsheduled visits to a healthcare provider (people with 1 or more) WMD of · people with asthma
It is very uncertain whether adherence education changes unsheduled visits to a healthcare provider (people with 1 or more)… compared with controls (very low certainty).
1 finding from 1 review
Absenteeism · people with asthma
1 finding from 1 review
Health‐related quality of life (AQLQ)Scale from: 1‐7 (higher is better) · people with asthma
1 finding from 1 review
Adherence · people with asthma
1 finding from 1 review
Exacerbations (OCS) · people with asthma
It is very uncertain whether electronic trackers or reminders (± feedback) changes exacerbations requiring OCS (people with at least 1) WMD of compared with controls (very low certainty).
1 finding from 1 review
Intervention not reported
Quality of life (AQLQ) · adults with asthma
1 finding from 1 review
Intervention not reported
Serious adverse events 49 weeks · adults with asthma
The intervention showed no clear difference in serious adverse events 49 weeks (low certainty).
1 finding from 1 review
Intervention not reported
Exacerbations requiring hospital admission 49 weeks · adults with asthma
The intervention showed no clear difference in exacerbations requiring hospital admission 49 weeks (low certainty).
1 finding from 1 review
Intervention not reported
Lung function (change in trough FEV1 L) · adults with asthma
1 finding from 1 review
Intervention not reported
Asthma control (ACQ) · adults with asthma
1 finding from 1 review
Intervention not reported
Any adverse events 49 weeks · adults with asthma
The intervention leads to lower any adverse events 49 weeks (high certainty).
1 finding from 1 review
Intervention not reported
Serious adverse events · children with chronic asthma
The intervention showed no clear difference in serious adverse events (moderate certainty).
1 finding from 1 review
Intervention not reported
Total number of withdrawals · children with chronic asthma
The intervention showed no clear difference in total number of withdrawals (moderate certainty).
1 finding from 1 review